Cargando…
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
BACKGROUND AND OBJECTIVE: Adult-onset Still’s disease (AOSD) is an idiopathic systemic inflammatory disease of unknown aetiology. Some patients exhibit resistance to conventional treatment during long-term therapy. Janus kinase inhibitors (JAKinibs) may contribute to the improvement in AOSD symptoms...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293510/ https://www.ncbi.nlm.nih.gov/pubmed/37010773 http://dx.doi.org/10.1007/s40268-023-00417-7 |